Life Sciences

spot_imgspot_img

ImmunoScape Appoints Peter Olagunju as CEO

ImmunoScape has appointed biotechnology executive Peter Olagunju as Chief Executive Officer as the Singapore- and Boston-based company prepares to advance its T-cell receptor (TCR)-based...

Synthekine Appoints Susan M. Molineaux as CEO to Lead Next Phase of Oncology Innovation

Clinical-stage biotechnology company Synthekine has appointed Susan M. Molineaux, Ph.D. as its new Chief Executive Officer, marking a leadership transition as the company advances...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img